ATE378053T1 - Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen - Google Patents
Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungenInfo
- Publication number
- ATE378053T1 ATE378053T1 AT04818828T AT04818828T ATE378053T1 AT E378053 T1 ATE378053 T1 AT E378053T1 AT 04818828 T AT04818828 T AT 04818828T AT 04818828 T AT04818828 T AT 04818828T AT E378053 T1 ATE378053 T1 AT E378053T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- renal disorders
- treating renal
- treating
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104264 | 2003-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378053T1 true ATE378053T1 (de) | 2007-11-15 |
Family
ID=34610099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04818828T ATE378053T1 (de) | 2003-11-18 | 2004-11-15 | Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7273860B2 (de) |
| EP (1) | EP1687006B1 (de) |
| JP (1) | JP4824573B2 (de) |
| CN (1) | CN100566719C (de) |
| AR (1) | AR046454A1 (de) |
| AT (1) | ATE378053T1 (de) |
| AU (1) | AU2004290925B2 (de) |
| BR (1) | BRPI0416706A (de) |
| CA (1) | CA2545802A1 (de) |
| DE (1) | DE602004010172T2 (de) |
| ES (1) | ES2297536T3 (de) |
| HK (1) | HK1097762A1 (de) |
| MX (1) | MXPA06005547A (de) |
| PL (1) | PL1687006T3 (de) |
| TW (1) | TWI344366B (de) |
| WO (1) | WO2005049035A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL149416A0 (en) * | 1999-11-19 | 2002-11-10 | Solvay Pharm Bv | Human enzymes of the metalloprotease family |
| AR049401A1 (es) | 2004-06-18 | 2006-07-26 | Novartis Ag | Aza-biciclononanos |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| US20060159748A1 (en) * | 2004-12-23 | 2006-07-20 | Rajesh Jain | Oral immediate release formulation of a poorly water-soluble active substance |
| US11844803B2 (en) * | 2017-12-11 | 2023-12-19 | Aetas Pharma Co., Ltd. | Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative |
| PL424453A1 (pl) * | 2018-01-31 | 2019-08-12 | Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością | Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) |
| JP7124130B2 (ja) * | 2018-06-22 | 2022-08-23 | シナクト ファーマ エーピーエス | 蛋白尿の治療 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0254032A3 (de) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Hemmer der neutralen Metallendopeptidase zur Behandlung von Hypertension |
| DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19638020A1 (de) | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
| DE19906310A1 (de) | 1999-02-16 | 2000-08-17 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von Bluthochdruck |
| DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| WO2003059939A1 (en) * | 2002-01-16 | 2003-07-24 | Solvay Pharmaceuticals B.V. | Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| PE20040468A1 (es) * | 2002-05-17 | 2004-09-14 | Novartis Ag | Combinacion de compuestos organicos |
-
2004
- 2004-11-15 DE DE602004010172T patent/DE602004010172T2/de not_active Expired - Lifetime
- 2004-11-15 CN CNB2004800330307A patent/CN100566719C/zh not_active Expired - Fee Related
- 2004-11-15 BR BRPI0416706-6A patent/BRPI0416706A/pt not_active IP Right Cessation
- 2004-11-15 AT AT04818828T patent/ATE378053T1/de not_active IP Right Cessation
- 2004-11-15 AU AU2004290925A patent/AU2004290925B2/en not_active Ceased
- 2004-11-15 ES ES04818828T patent/ES2297536T3/es not_active Expired - Lifetime
- 2004-11-15 TW TW093134862A patent/TWI344366B/zh not_active IP Right Cessation
- 2004-11-15 MX MXPA06005547A patent/MXPA06005547A/es active IP Right Grant
- 2004-11-15 WO PCT/EP2004/052963 patent/WO2005049035A1/en active IP Right Grant
- 2004-11-15 EP EP04818828A patent/EP1687006B1/de not_active Expired - Lifetime
- 2004-11-15 CA CA002545802A patent/CA2545802A1/en not_active Abandoned
- 2004-11-15 JP JP2006540446A patent/JP4824573B2/ja not_active Expired - Fee Related
- 2004-11-15 AR ARP040104208A patent/AR046454A1/es not_active Application Discontinuation
- 2004-11-15 PL PL04818828T patent/PL1687006T3/pl unknown
- 2004-11-16 US US10/988,847 patent/US7273860B2/en not_active Expired - Fee Related
-
2007
- 2007-04-24 HK HK07104298.4A patent/HK1097762A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL1687006T3 (pl) | 2008-01-31 |
| CA2545802A1 (en) | 2005-06-02 |
| EP1687006A1 (de) | 2006-08-09 |
| BRPI0416706A (pt) | 2007-01-16 |
| US20050137183A1 (en) | 2005-06-23 |
| TW200526228A (en) | 2005-08-16 |
| ES2297536T3 (es) | 2008-05-01 |
| EP1687006B1 (de) | 2007-11-14 |
| AU2004290925B2 (en) | 2010-07-01 |
| TWI344366B (en) | 2011-07-01 |
| AR046454A1 (es) | 2005-12-07 |
| DE602004010172D1 (de) | 2007-12-27 |
| AU2004290925A1 (en) | 2005-06-02 |
| DE602004010172T2 (de) | 2008-09-11 |
| CN100566719C (zh) | 2009-12-09 |
| MXPA06005547A (es) | 2006-08-17 |
| HK1097762A1 (en) | 2007-07-06 |
| JP2007511582A (ja) | 2007-05-10 |
| US7273860B2 (en) | 2007-09-25 |
| WO2005049035A1 (en) | 2005-06-02 |
| JP4824573B2 (ja) | 2011-11-30 |
| CN1878557A (zh) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE430555T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| ATE515261T1 (de) | Zusammensetzungen zur behandlung von diabetes | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| EP1633362A4 (de) | Verbindungen, verfahren und pharmazeutische zusammensetzungen zur hemmung von parp | |
| ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
| EP1851237A4 (de) | Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| DE602004022036D1 (de) | Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE326842T1 (de) | Zusammensetzung zur saatgutbehandlung | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE602006013009D1 (de) | Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs | |
| ATE378053T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| DE602004026067D1 (de) | Gerät zur Behandlung von Füßen | |
| DE10394347T5 (de) | Eine synergistische Zusammensetzung zur Behandlung von Hyperlipidämie | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| ATE446757T1 (de) | 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |